Cargando…
Review: Multiple system atrophy: emerging targets for interventional therapies
Multiple system atrophy (MSA) is a fatal orphan neurodegenerative disorder that manifests with rapidly progressive autonomic and motor dysfunction. The disease is characterized by the accumulation of α‐synuclein fibrils in oligodendrocytes that form glial cytoplasmic inclusions, a neuropathological...
Autores principales: | Stefanova, N., Wenning, G. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788141/ https://www.ncbi.nlm.nih.gov/pubmed/26785838 http://dx.doi.org/10.1111/nan.12304 |
Ejemplares similares
-
Animal models of multiple system atrophy
por: Stefanova, Nadia, et al.
Publicado: (2015) -
Is Multiple System Atrophy a Prion-like Disorder?
por: Jellinger, Kurt A., et al.
Publicado: (2021) -
Current experimental disease-modifying therapeutics for multiple system atrophy
por: Lemos, Miguel, et al.
Publicado: (2021) -
Towards translational therapies for multiple system atrophy
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2014) -
Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
por: Sidoroff, Victoria, et al.
Publicado: (2022)